학술논문
One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study
Document Type
Short Communication
Author
Source
In Ophthalmology Retina December 2019 3(12):1107-1109
Subject
Language
ISSN
2468-6530